Biologics and Biosimilars – Video
This short animated video outlines Boehringer Ingelheim’s commitment to developing novel treatments such as biologics and biosimilars.
What you'll learn:
- How biologics have transformed the treatment of diseases and expanded access to vital medicines.
- Key requirements for the development of biosimilars.
- BI’s goals in developing novel biologics and biosimilars.
Related Resources
Biosimilars - HCP Resource
Biosimilar Development and Manufacturing Processes - Slide Deck
Review the characteristics, development, and regulation of biosimilars.
View Resource
Biosimilars - HCP Resource
Biosimilar Interchangeability and Extrapolation - Booklet
Review how biosimilars and interchangeable biosimilars are approved.
View Resource
Biosimilars - HCP Resource
Biosimilar Interchangeability Map
An interactive map detailing interchangeable biosimilar regulations by state.
View Resource
